As for haematological malignancies, Rana et al. reported that patients with chronic lymphocytic leukaemia (CLL) exhibit significantly reduced levels of MLT apart from changes in the expression of some circadian “clock genes” compared to healthy subjects, which suggests that the decreased production of MLT may elevate the risk of CLL [11]. This evidence concerns the gene CLOCK and B-cell chronic lymphocytic leukemia.